IGC Pharma
IGC
#10743
Rank
NZ$37.18 M
Marketcap
NZ$0.32
Share price
-4.61%
Change (1 day)
-46.76%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -NZ$11.2 Million

According to IGC Pharma's latest financial reports the company's current earnings are NZ$1.18 Million. In 2025 the company made an earning of -NZ$9.68 Million, an increase over its 2024 earnings that were of -NZ$15.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$11.2 Million15.7%
2025 -NZ$9.68 Million-39.35%
2024 -NZ$15.95 Million-37.72%
2023 -NZ$25.62 Million1.19%
2022 -NZ$25.32 Million21.96%
2021 -NZ$20.76 Million27.13%
2020 -NZ$16.33 Million57.16%
2019 -NZ$10.39 Million85.47%
2018 -NZ$5.61 Million52.76%
2017 -NZ$3.67 Million-16.23%
2016 -NZ$4.38 Million-28.75%
2015 -NZ$6.15 Million-19.59%
2014 -NZ$7.64 Million6.79%
2013 -NZ$7.16 Million-9.47%
2012 -NZ$7.91 Million-74.03%
2011 -NZ$30.43 Million119.78%
2010 -NZ$13.85 Million62.02%
2009 -NZ$8.55 Million74.39%
2008 -NZ$4.9 Million-313.12%
2007 NZ$2.29 M-35.94%
2006 NZ$3.58 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
NZ$1.41 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
NZ$1.32 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-NZ$0.27 Billion 2,142.84%๐Ÿ‡บ๐Ÿ‡ธ USA